Disc Medicine Newsroom

Disc Medicine Is Maintained at Buy by HC Wainwright & Co.

Dow JonesNov 14 03:09

Disc Medicine Analyst Ratings

BenzingaNov 14 02:59

Stifel Maintains Disc Medicine(IRON.US) With Buy Rating, Maintains Target Price $79

Futu NewsNov 13 21:36

Morgan Stanley Maintains Disc Medicine(IRON.US) With Buy Rating, Maintains Target Price $85

Futu NewsNov 13 21:36

BMO Capital Maintains Disc Medicine(IRON.US) With Buy Rating, Maintains Target Price $112

Futu NewsNov 13 20:31

H.C. Wainwright Maintains Disc Medicine(IRON.US) With Buy Rating, Raises Target Price to $118

Futu NewsNov 13 19:32

Douglas Tsao's Buy Rating on Disc Medicine Driven by Program Advancements and Strategic Financing

TipRanksNov 13 19:28

LifeSci Capital Maintains Disc Medicine(IRON.US) With Buy Rating, Maintains Target Price $85

Futu NewsNov 13 05:32

Disc Medicine's Strong Financial Position and Promising Clinical Developments Drive Buy Rating

TipRanksNov 13 04:42

Wedbush Raises Disc Medicine Price Target to $83 From $75, Maintains Outperform Rating

MT NewswiresNov 13 03:12

Disc Medicine Is Maintained at Sector Outperform by Scotiabank

Dow JonesNov 6 08:00

Disc Medicine Price Target Raised to $70.00/Share From $62.00 by Scotiabank

Dow JonesNov 6 08:00

Disc Medicine Analyst Ratings

BenzingaNov 5 22:36

HC Wainwright & Co. Reiterates Buy on Disc Medicine, Maintains $70 Price Target

BenzingaNov 5 22:36

Scotiabank Reaffirms Their Buy Rating on Disc Medicine (IRON)

TipRanksNov 5 21:57

A Quick Look at Today's Ratings for Disc Medicine(IRON.US), With a Forecast Between $70 to $112

Futu NewsNov 5 21:07

Morgan Stanley Upgrades Disc Medicine to Overweight From Equalweight, Price Target Is $85

MT NewswiresNov 5 21:03

Disc Medicine (IRON) Gets a Buy From Wells Fargo

TipRanksNov 5 10:01

Scotiabank Maintains Disc Medicine(IRON.US) With Buy Rating, Maintains Target Price $62

Futu NewsOct 28 20:36

Disc Medicine Analyst Ratings

BenzingaOct 28 20:22